文献速递神经核医学

尼曼-匹克C型病相关的代谢减低与萎缩模式

Hypometabolism and atrophy patterns associated with Niemann-Pick type C.
PubMed 文献 · EJNMMI Res · 2025-02-26

本研究纳入22例尼曼-匹克C型病(NP-C)患者,在基线时进行MRI、[18F]FDG PET和临床评估,开展横断面和纵向影像研究。结果显示[18F]FDG PET在检测NP-C神经退行性改变方面可能比MRI更敏感,并揭示小脑、丘脑和扣带回广泛代谢减低;纵向分析显示小脑代谢减低每年-12%(p<0.001)。作者认为[18F]FDG PET可能是NP-C诊断和疾病进展研究的有前景工具。

要点

  • MRI显示小脑和丘脑显著萎缩(d=1.56,p<0.0001;d=1.09,p<0.001),额叶和海马受累较轻。
  • [18F]FDG PET显示小脑、丘脑和扣带回广泛代谢减低(d=1.42,p<0.0001),额颞区中度代谢减低。
  • 纵向[18F]FDG PET显示小脑代谢减低最明显(每年-12%,p<0.001);接受米格鲁特治疗的患者较未治疗者小脑代谢减低进展有减弱趋势(p=0.10)。

核心结论

  • 本研究描绘了NP-C特有的代谢减低模式,可与其他神经退行性疾病区分,提示[18F]FDG PET可能是NP-C诊断和疾病进展研究的有前景工具。

研究设计与样本

  • 横断面和纵向影像研究,纳入22例NP-C患者,在基线进行MRI、[18F]FDG PET和临床评估。
  • 试验注册号XUNTA 2015/140,注册日期2015年4月21日。

主要发现

  • 组水平MRI分析显示小脑显著萎缩(d=1.56,p<0.0001)和丘脑显著萎缩(d=1.09,p<0.001),额叶和海马受累较轻。
  • [18F]FDG PET显示小脑、丘脑和扣带回广泛代谢减低(d=1.42,p<0.0001),以及广泛额颞区中度代谢减低。
  • 医师对个体PET图像视觉评估报告17/22例患者在小脑、丘脑和前、后扣带回存在显著代谢减低。
  • 小脑代谢减低和萎缩均与共济失调相关,[18F]FDG PET指示更强(p<0.0001 vs. MRI p=0.07)。
  • 内侧颞叶萎缩与认知障碍相关(p<0.05),额叶代谢减低与行为障碍轻度相关(p<0.07)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Niemann-Pick disease type C (NP-C) is a rare genetic lysosomal lipid storage disorder characterized by progressive neurological impairment. Early diagnosis is critical for initiating treatment with miglustat, which can decelerate disease progression. In this study, we evaluated a cohort of 22 NP-C patients who underwent MRI, [18F]FDG PET, and clinical assessment at baseline. We performed a cross-sectional and longitudinal imaging study evaluating the role of [18F]FDG PET as an adjunct diagnostic tool for NP-C alongside MRI, the current neuroimaging standard. RESULTS: Group-level MRI analysis identified significant cerebellar and thalamic atrophy (d = 1.56, p < 0.0001 and d = 1.09, p < 0.001, respectively), with less pronounced involvement of the frontal lobe and hippocampus, which aligned with existing neuropathological understanding and guidelines. Conversely, [18F]FDG PET imaging revealed extensive hypometabolism in the cerebellum, thalamus, and cingulate cortex (d = 1.42, p < 0.0001), and moderate hypometabolism in broad frontotemporal areas. [18F]FDG PET provided higher effect sizes across all brain regions, including regions without apparent atrophy, which suggests that it may be more sensitive than MRI for detecting NP-C neurodegenerative changes. Single-subject visual assessment of individual PET images further validated the clinical utility of [18F]FDG PET, with significant hypometabolism observed in the cerebellum, thalamus and anterior and posterior cingulate reported by physicians in 17/22 patients. Both hypometabolism and atrophy in the cerebellum were associated with ataxia, (more strongly indicated by [18F]FDG PET, p < 0.0001 vs. MRI, p = 0.07). Medial temporal lobe atrophy was associated with cognitive impairment (p < 0.05), and frontal hypometabolism was slightly related to behavioural impairment (p < 0.07). Longitudinal [18F]FDG PET analysis revealed progressive subcortical, cortical and cerebellar hypometabolism, which was most pronounced in the cerebellum (-12% per year, p < 0.001). Patients treated with miglustat showed a trend towards attenuated cerebellar hypometabolism progression compared to untreated patients (p = 0.10). CONCLUSIONS: Our findings delineate a discernible hypometabolism pattern specific to NP-C that distinguishes it from other neurodegenerative conditions, thus suggesting that [18F]FDG PET might be a promising tool for NP-C diagnosis and to study disease progression. TRIAL REGISTRATION: XUNTA 2015/140. Registered 21 April 2015.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Silva-Rodríguez J, Castro C, Cortés J, et al. Hypometabolism and atrophy patterns associated with Niemann-Pick type C. EJNMMI Res. 2025. PMID: 40009086. doi:10.1186/s13550-025-01208-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。